. Lowest values in complicated and uncomplicated groups were seen on 1st and 2nd day respectively. 5). The mean value in complicated group (73.94 ± 34.07, 77.97 ± 20.00 and 92.48 + 20.88 on 1st, 2nd and 3rd day respectively) was much lower than uncomplicated group (104.28 ± 26.18, 96.99 ± 16.53 and 120.21 ± 22.97 on, 1st, 2nd and 3rd day respectively) following myocardial infarction (P < .00l 
Introduction
In the affluent countries every third death in sixth decade of life is caused by Ischaemic Heart Disease (WHO 1974 
Pseudocholinesterase in Relation to Complication and Mortality
It is well known that a massive rise in the levels of SGOT, LDH, CPK, during infarction suggest large infarct with poor prognosis. Charles, B. Moore (1957) reported that earlier and rapid fall in the pseudocholinesterase level may have a poor prognosis, a persistent low level in patients having complication may be a grave prognostic sign. In
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his study all the fatal cases had marked fall in pseudocholinesterase levels before death. Mutalik et al (1976) found that in complicated cases the levels of pseudocholinesterase were much lower than uncomplicated. G.S. Sainani et al (1979) studied the patients of infarction having cardiac arrhythmias and found that patients having tachyarrhythmias had little higher value in comparison to patients with bradyarrhythmias though the difference was not significant statistically.
Material and Methods
The 
Criteria for Exclusion and Inclusion
Patients admitted after 48 hours of onset of acute chest pain were excluded from the study. A thorough clinical check up was done in every case and the cases with liver diseases (Hepatitis, Cirrhosis, Malignancy) malignancies, chronic renal failure, Dermatomyositis, Nephrotic Syndrome and toxic goitre were excluded from the study. Patients receiving sympathomimetic drugs, phenothiazine derivative and atropine or its derivatives were excluded from study. However, patients receiving infrequent administration of these drugs were included in the study. The study was designed in the following fashion 1. Clinico-Electrocardiographic study.
2. Haematological study.
3. Biochemical study.
Pseudocholinesterase Activity Estimation
In Controls: Pseudocholinesterase estimation was done once in age and sex matched normal persons.
In cases of Acute Myocardial Infarction:
Pseudocholinesterase activity estimation was done at the time of admission and then on 1st, 2nd, 3rd, 5th, 7th and 10th day of Acute Chest Pain.
Observations
In the present study a total of 75 cases were studied, out of which 50 cases were of acute myocardial infarction and 25 were controls. 1960) . Disparity in the incidence of myocardial infarction in males and females is greatest before the age of forty and diminishes after the age of seventy years (Annastessiades, 1961). Lesser susceptibility of women to myocardial infarction in early age has been attributed to the effects of estrogens or other sex hormone (James et al, 1955) . In the present study there was only one female less than the age of 40 years. Average age (Mean) of females was little higher than males in this study (Male 54.1 years, females 55.8 years). Similar results were observed by Annastassiades et al (1961) . Maximum number of patients was in the 6th decade of life followed by 5th and 7th decade (32%, and 26% each respectively). Master et al (1939), Mintz and Kartz (1947) in their study also observed similar results. There was no significant difference seen in the incidence of complications in either sex (Male: female ratio is 1:1 approximately)
Incidence and Pattern of Pseudocholinesterase Activity in Acuie Myocardial Infarction
In the present study fall in the levels of pseudocholinesterase was observed in all 44(100%) confirmed cases of acute myocardial infarction. This finding was consistent with the findings of other workers (Basu et a1,1972; Mutalik et a1, 1976; Vachharajani et al, 1976; Sharma et a1, 1978; Sainani et al, 1979 , Chawhan et a1,1982 . In this study we have observed a significant fall in the levels of pseudocholinesterase on 1st day following infarction and low values were seen on very same day in most of the cases. Low values following infarction have been observed by various authors on 1st day (Basu et a1,1972 , Vachharajani, 1976 Mutalik et a1, 1976; Sharma et a1, 1978; Sainani et al, 1979; Chawhan et al, 1982) It is very difficult for us to comment whether pseudo-cholinesterase levels start falling in early hours of infarction as none of our patients in the study group came to hospital before 8 to 10 hours of chest pain. In this study out of 29 complicated cases arrived in 24 hours of chest pain, 19 (65.51%) had lowest value while remaining 10 and 2 out of five cases, who arrived on 2nd day had lowest activity on 2 nd day, remaining three patients had lowest value on 3rd day. In uncomplicated group 3 (37.5%) out of 8 patients who arrived on 1st day, had lowest activity on 1st day, remaining 5 (62.5%) had lowest activity on 2nd day and remaining two who came on 2nd day of infarction had lowest activity on 3rdday. It was observed in this study that minimum normal values in patients with arrhythmias and pump failure were attained on 7th and 10th day respectively. While Chawhan et al (1982) had inferred that patients with left ventricular failure and arrhythmias had minimum normal values on 10th and after 10 days respectively. Out of 6 cases who had lowest activity of pseudocholinesterase on 10th day, 2 cases expired in further follow up, and 4 patients improved and were discharged in satisfactory condition.
Duration

Summary & Conclusions
In myocardial infarction, earlier and rapid fall in the pseudocholinestrase level may have a poor prognosis, a persistent low level in patients having complication may be a grave prognostic sign, so we suggest that determination of pseudocholinesterase in patients of acute myocardial infarction before discharge of patient may be an additional useful test in such type of cases.
